科学图书馆
-
From Early Pharmacology to Recent Pharmacology Interventions in Acute Coronary SyndromesSzummer K, Jernberg T, Wallentin L. -
OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)M Banach, PE Penson, ACS EuroPath Central & South European Countries Project et al.
-
Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary AngiographyRHM Furtado, JC Nicolau, JP Guo et al.
-
Efficacy and Safety of Low-Dose Colchicine after Myocardial InfarctionTardif JC, Kouz S, Waters DD et al.
-
Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE TrialHenriques JP, Hoebers LP, EXPLORE Trial Investigators.
-
Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES TrialGG Schwartz, PG Steg, ODYSSEY OUTCOMES Committees and Investigators et al.
-
The Prognostic Significance of Periprocedural Infarction in the Era of Potent Antithrombotic Therapy: The PRAGUE-18 SubstudyJ Dusek, Z Motovska, Prague-18 Study Group et al.
-
Linking Spontaneous Coronary Artery Dissection, Cervical Artery Dissection, and Fibromuscular Dysplasia: Heart, Brain, and KidneysParé G, Bhatt DL.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
